RxDoctor Payments Data

Gary Kaplan, MD

Internal Medicine · Bellmore, NYNPI 1528148608

Payments from drug & device makers

$3,439in general payments, 2019–2025

Across 122 payments — averaging $28.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Galderma Laboratories, L.p.$33
  • Merz North America, Inc.$33
  • Renalytix AI, Inc.$16

What the payments were for

  • Speaking & faculty fees$93027%
  • Food & beverage$2,50973%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)117$3,357
Galderma Laboratories, L.p.2$33
Merz North America, Inc.2$33
Renalytix AI, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,439 in reported general payments places this provider in the 85th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Medicare billing

Part B allowed, 2024
$51,594
Medicare patients
47
Services billed
492

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valsartan52$1,097
Rosuvastatin Calcium124$996
Levothyroxine Sodium42$677
Nifedipine ErNifedipine13$408
FenofibrateFenofibrate Nanocrystallized18$321
Fenofibrate27$279
Metformin Hcl26$247
Lisinopril54$239
Metoprolol Succinate26$202
Pravastatin Sodium28$194
Atorvastatin Calcium62$175
Diltiazem 24hr Er (Cd)Diltiazem Hcl17$137
Enalapril Maleate12$123
Ezetimibe24$108
Terazosin Hcl11$104

Paid to pharmacies, not to this prescriber.

Other internal medicine in Bellmore

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →